Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Pollyea

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Annals of Internal Medicine|April 25, 2022
Professional CourtesyDaniel A Pollyea
Journal of the National Comprehensive Cancer Network : JNCCN|November 26, 2019
Therapeutic Advances in First-Line Management of Acute Myeloid LeukemiaDaniel A Pollyea
Best Practice & Research. Clinical Haematology|November 24, 2018
Which novel agents for acute myeloid leukemia are likely to change practice?Daniel A Pollyea
Haematologica|October 1, 2025
The French-American-British classification system for acute myeloid leukemiaDaniel A Pollyea
Hematology. American Society of Hematology. Education Program|December 4, 2018
New drugs for acute myeloid leukemia inspired by genomics and when to use themDaniel A Pollyea
Best Practice & Research. Clinical Haematology|December 13, 2023
Progress and challenges in the acute leukemia fieldDaniel A Pollyea
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Next-Generation Sequencing and Eating of the Tree of KnowledgeDaniel A Pollyea
American Journal of Hematology|June 11, 2019
Acute myeloid leukemia drug development in the post-venetoclax eraDaniel A Pollyea
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Venetoclax in AML: Where We Are and Where We Are HeadedDaniel A Pollyea
Current Hematologic Malignancy Reports|July 9, 2018
Shutting Down Acute Myeloid Leukemia and Myelodysplastic Syndrome with BCL-2 Family Protein InhibitionPrashant Sharma, Daniel A Pollyea
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Annals of Internal Medicine|April 25, 2022
Professional CourtesyDaniel A Pollyea
Journal of the National Comprehensive Cancer Network : JNCCN|November 26, 2019
Therapeutic Advances in First-Line Management of Acute Myeloid LeukemiaDaniel A Pollyea
Best Practice & Research. Clinical Haematology|November 24, 2018
Which novel agents for acute myeloid leukemia are likely to change practice?Daniel A Pollyea
Haematologica|October 1, 2025
The French-American-British classification system for acute myeloid leukemiaDaniel A Pollyea
Hematology. American Society of Hematology. Education Program|December 4, 2018
New drugs for acute myeloid leukemia inspired by genomics and when to use themDaniel A Pollyea
Best Practice & Research. Clinical Haematology|December 13, 2023
Progress and challenges in the acute leukemia fieldDaniel A Pollyea
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Next-Generation Sequencing and Eating of the Tree of KnowledgeDaniel A Pollyea
American Journal of Hematology|June 11, 2019
Acute myeloid leukemia drug development in the post-venetoclax eraDaniel A Pollyea
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Venetoclax in AML: Where We Are and Where We Are HeadedDaniel A Pollyea
Current Hematologic Malignancy Reports|July 9, 2018
Shutting Down Acute Myeloid Leukemia and Myelodysplastic Syndrome with BCL-2 Family Protein InhibitionPrashant Sharma, Daniel A Pollyea
Pageof 18